2017 Press Releases

Receive E-mail AlertsE-mail Alerts

Keyword Search
 
2017 | 2016 | 2015 | 2014 | 2013
DateTitle 
May 9, 2017Geron Corporation Reports First Quarter 2017 Financial Results and Recent Events
MENLO PARK, Calif., May 09, 2017 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today reported financial results for the first quarter ended March 31, 2017 and recent events. First Quarter 2017 Results For the first quarter of 2017, the co... 
Printer Friendly Version
Apr 25, 2017Geron 2017 Annual Meeting of Stockholders to be Held on May 9
First Quarter 2017 Financial Results Expected Same Day MENLO PARK, Calif., April 25, 2017 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) will hold its 2017 Annual Meeting of Stockholders, on Tuesday, May 9, 2017, at 4:00 p.m. PDT. Geron’s ... 
Printer Friendly Version
Apr 10, 2017Geron Announces Completion of Second Internal Data Reviews for Imetelstat Trials Being Conducted by Janssen
Both IMerge and IMbark Continue in Lower Risk Myelodysplastic Syndromes and Relapsed or Refractory Myelofibrosis Conference Call Scheduled for 8:00 a.m. EDT Today, April 10 MENLO PARK, Calif., April 10, 2017 (GLOBE NEWSWIRE) -- Geron Corporatio... 
Printer Friendly Version
Apr 9, 2017Geron Announces Conference Call on April 10 at 8:00 A.M. Eastern Time
MENLO PARK, Calif., April 09, 2017 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) will host a conference call on April 10, 2017, at 8:00 a.m. Eastern Time to provide an update on the ongoing imetelstat Phase 2/3 trial in myelodysplastic syndro... 
Printer Friendly Version
Apr 5, 2017Geron Reports Imetelstat Presentation at American Association for Cancer Research Annual Meeting
MENLO PARK, Calif., April 05, 2017 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today announced a poster presentation by Janssen Research & Development, LLC describing non-clinical data on the telomerase inhibitor imetelstat at the 2017 ... 
Printer Friendly Version
Mar 2, 2017Geron Announces Presentation at American Association for Cancer Research Annual Meeting
MENLO PARK, Calif., March 02, 2017 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today announced an abstract submitted by Janssen Research & Development, LLC describing non-clinical data on imetelstat has been accepted for presentation as... 
Printer Friendly Version
Mar 1, 2017Geron Corporation Reports Fourth Quarter and Annual 2016 Financial Results
Conference Call Scheduled for 4:30 p.m. ET Today, March 1 MENLO PARK, Calif., March 01, 2017 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today reported financial results for the fourth quarter and year ended December 31, 2016 and recent ev... 
Printer Friendly Version
Feb 22, 2017Geron Announces Conference Call to Discuss Fourth Quarter and Annual 2016 Financial Results
MENLO PARK, Calif., Feb. 22, 2017 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) will announce its financial results for the fourth quarter and year ended December 31, 2016, on Wednesday, March 1, 2017, after the market close. Geron’s manageme... 
Printer Friendly Version
 Print Page |  E-mail Page | RSS Feeds RSS Feeds | E-mail Alerts E-mail Alerts